Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shuji Sumino"'
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 12, Pp 2940-2949 (2018)
Background: With the goal of global eradication of poliomyelitis due to wild-type viruses within sight, WHO now recommends that infants receive at least one dose of trivalent inactivated poliovirus vaccine (IPV) with bivalent OPV (types 1 and 3) repl
Externí odkaz:
https://doaj.org/article/79db6f39ce024268abceb9e2009dda56
Publikováno v:
Human Vaccines & Immunotherapeutics
Background: With the goal of global eradication of poliomyelitis due to wild-type viruses within sight, WHO now recommends that infants receive at least one dose of trivalent inactivated poliovirus vaccine (IPV) with bivalent OPV (types 1 and 3) repl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3031c8fb5999cfc40c7c132ffc1fc18
https://doi.org/10.1080/21645515.2018.1504538
https://doi.org/10.1080/21645515.2018.1504538
Publikováno v:
Vaccine. 36:2968-2972
Background Japan licensed the conjugate Haemophilus influenzae type b vaccine, Vaxem™ Hib, based on clinical studies using subcutaneous injection. The present study was performed to ensure this vaccine is suitable for intramuscular injection in Jap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c1e1004068ad1693a99f0b6445d1bb4
https://doi.org/10.1016/j.vaccine.2018.04.040
https://doi.org/10.1016/j.vaccine.2018.04.040
Autor:
Yuka Koizumi, Yohei Takanami, Nodoka Mitsuya, Yukihiro Akeda, Yumi Hattori, Kayoko Sugizaki, Shuji Sumino, Kazunori Oishi
Publikováno v:
Vaccine. 36:1528-1532
Haemophilus influenzae type b (Hib) conjugate vaccines have drastically reduced disease incidence worldwide. Protection against Hib infection has relied on the serum bactericidal activity (SBA) of antibodies to the Hib capsular polysaccharide (polyri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f324d8c424e8bf4e6df5a6ff764a46e
https://doi.org/10.1016/j.vaccine.2018.02.011
https://doi.org/10.1016/j.vaccine.2018.02.011
Publikováno v:
Vaccine. 36(21)
Japan licensed the conjugate Haemophilus influenzae type b vaccine, Vaxem™ Hib, based on clinical studies using subcutaneous injection. The present study was performed to ensure this vaccine is suitable for intramuscular injection in Japanese child
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::90a7e3338d3497ca5adca76bff6f7082
https://pubmed.ncbi.nlm.nih.gov/29685594
https://pubmed.ncbi.nlm.nih.gov/29685594
Autor:
Nodoka Mitsuya, Kayoko Sugizaki, Osamu Kogawara, Yohei Takanami, Takehiro Togashi, Shuji Sumino
Publikováno v:
Vaccine. 34(38)
BackgroundBroad use of monovalent Haemophilus influenzae type b (Hib) conjugate vaccines based on the capsular polysaccharide polyribosyl-ribitol phosphate (PRP), has significantly reduced invasive Hib disease burden in children worldwide, particular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::443f31f9395e61ba12263adf7b178c72
https://pubmed.ncbi.nlm.nih.gov/27265451
https://pubmed.ncbi.nlm.nih.gov/27265451